| Literature DB >> 32334608 |
Zhongfei Bai1,2,3, Kenneth N K Fong4, Jack Jiaqi Zhang1, Josephine Chan5, K H Ting6.
Abstract
BACKGROUND: A substantial number of clinical studies have demonstrated the functional recovery induced by the use of brain-computer interface (BCI) technology in patients after stroke. The objective of this review is to evaluate the effect sizes of clinical studies investigating the use of BCIs in restoring upper extremity function after stroke and the potentiating effect of transcranial direct current stimulation (tDCS) on BCI training for motor recovery.Entities:
Keywords: Brain-computer interface; Hemiparetic upper extremity function; Motor imagery; Movement attempt; Neural mechanism; Stroke
Mesh:
Year: 2020 PMID: 32334608 PMCID: PMC7183617 DOI: 10.1186/s12984-020-00686-2
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Fig. 1Flow chart of study selection
Characteristics of the single-group studies
| Study, year | n | Age (years)a | Time since strokea | Brain signal for BCI | BCI intervention | Dosage of BCI | Outcome measures | Main results |
|---|---|---|---|---|---|---|---|---|
| Buch et al. (2008) [ | 8 | 58.2 ± 7.0 | 25.2 ± 11.6 (mo) | MEG, mu | BCI-orthosis | 1–2 h/d, 3–5 d/wk., 3–8 wk | MRC | Increased mu rhythm modulation, but no clinical change in MRC. |
| Prasad et al. (2010) [ | 5 | 58.6 ± 8.98 | 28 ± 15.4 (mo) | EEG, mu, beta | BCI-visual feedback | 30 min/d, 2 d/wk., 6 wk | ARAT, MRC, 9-HPT | Positive improvement in at least one outcome in all subjects. |
| Tung et al. (2013) [ | 6 | Unknown | Unknown | EEG | BCI-robot | 1 h/d, 5 d/wk., 2 wk | FMA-UE | Significant improvement in FMA-UE after BCI. |
| Ono et al. (2014) [ | 12 | 57.6 ± 11.8 | 30.8 ± 41.3 (mo) | EEG, mu, beta | BCI-visual feedback/somatosensory feedback | 1 h/d, 12–20 d | SIAS, EMG | BCI training with somatosensory feedback was more effective than that with visual feedback. |
| Morone et al. (2015) [ | 8 | 60 ± 10.9 | 24.4 ± 21.2 (wk) | EEG, beta | Con-rehab + BCI-visual feedback | 30 min/d, 3 d/wk., 4 wk | FMA-UE, NIHSS, BI | Positive improvement in all subjects and half of them had improvements higher than the MCID. |
| Kawakami et al. (2016) [ | 29 | 50.6 ± 10.9 | 48 ± 41.4 (mo) | EEG, mu | 40 min standard training + BCI-orthosis | 45 min/d, 5 d/wk., 2 wk | FMA-UE, MAL, MAS | Significant improvement in FMA-UE and MAL scores after BCI training. |
| Kotov et al. (2016) [ | 5 | 47.0 ± 7.7 | 2 mo-4 yr | EEG | BCI-exoskeleton | 8–10 d | NIHSS, MAS, BI, mRS | All patients showed decreases in neurological deficit after BCI training. |
| Bundy et al. (2017) [ | 10 | 58.6 ± 10.3 | 73.6 ± 104.2 (mo) | EEG, mu, beta | BCI-exoskeleton | 10–120 min/d, 5 d/wk., 12 wk | ARAT, MAS, | Significant improvement in ARAT after BCI training. |
| Ibáñez et al. (2017) [ | 4 | 54.3 ± 11.8 | 4 ± 0.8 (yr) | EEG, 7–30 Hz, Bereitschafts potential | BCI-FES | 10 days in one month | FMA-UE | Improved scores in FMA-UE after BCI training. |
| Sullivan et al. (2017) [ | 6 | 57.5 ± 7.9 | 51.5 ± 41.9 (mo) | EEG, MRCP | BCI-exoskeleton | 12 d in 5 wk | FMA-UE | Significant improvement in FMA-UE after BCI training. |
| Nishimoto et al. (2018) [ | 26 | 50.2 ± 11.1 | 47.4 ± 43.9 (mo) | EEG, mu | BCI-exoskeleton + FES | 40 min/d, 10 d | FMA-UE, MAL | Significant improvement in FMA-UE and MAL after BCI training. |
| Chowdhury et al. (2018) [ | 4 | 44.75 ± 15.69 | 7 ± 1.15 (mo) | EEG, mu, low beta | BCI-exoskeleton | 2–3 d/wk., 6 wk | ARAT, GS | The group mean changes from baseline in GS and ARAT were + 6.38 kg and + 5.66, respectively. |
| Norman et al. (2018) [ | 8 | 59.5 ± 11.8 | At least 6 (mo) | EEG, mu, beta | BCI- visual feedback | 3 d/wk., 4 wk | BBT | Hand function, measured by BBT improved by 7.3 ± 7.5 versus 3.5 ± 3.1 in those with and without SMR control. |
| Remsik et al. (2018) [ | 21 | 61.6 ± 15 | 1127 ± 1327 (d) | EEG | BCI- visual feedback, FES | 2 h/d, 15 d | ARAT, 9-HPT, SIS | Significant improvement in ARAT after BCI training. |
| Tabernig et al. (2018) [ | 8 | 61.2 ± 19.0 | 36.8 ± 24.2 (mo) | EEG, beta | BCI-FES | 1 h/d, 4 d/wk., 5 wk | Modified FMA-UE | Significant improvement in modified FMA-UE after BCI training. |
| Carino-Escobar et al. (2019) [ | 9 | 58.1 ± 12.1 | 158 ± 74 (d) | EEG, mu, beta | BCI-orthosis | 3 d/wk., 4 wk | FMA-UE | Six out of nine subjects had higher scores in FMA-UE after BCI training. |
| Foong et al. (2019) [ | 11 | 55.2 ± 11.0 | 333.7 ± 179.6 (d) | EEG | Standard arm therapy + BCI-visual feedback | 1 h/d, 2 d/wk., 6 wk | FMA-UE, ARAT | Significant improvement in FMA-UE after BCI training. |
| Rathee et al. (2019) [ | 4 | 62.5 ± 5.7 | 23 ± 4.2 (mo) | EEG, EMG | BCI-exoskeleton | 6 wk | ARAT, GS | Significant improvement in ARAT and GS after BCI training. |
aData is reported as means (SD)
mo month(s), yr year(s), wk. weak(s), h hour(s), d day(s), BCI Brain-computer interface, MEG Magnetoencephalography, MRC Medical Research Council scale, SIAS Stroke Impairment Assessment Set, EEG Electroencephalography, ARAT Action Research Arm Test, 9-HPT Nine-Hole Peg Test, NIHSS National Institute of Health Stroke Scale, BI Barthel Index, EMG Electromyography, SMR Sensorimotor rhythm, FES Functional electrical stimulation, SIS Stroke Impact Scale, con-rehab conventional rehabilitation, FMA-UE Fugle-Meyer assessment-upper extremity, MCID Minimal clinically important difference, MAL Motor activity log, GS Grip strength, MAS Modified Ashworth scale, mRS modified Rankin scale, MRCP Movement-related cortical potentials, BBT Box and Block Test
Characteristics of the controlled studies
| Study, year | Design | n (E/C) | Age (years)a | Time since strokea | Brain signal for BCI | Experimental group | Control group | Dosage of BCI | Outcome measures |
|---|---|---|---|---|---|---|---|---|---|
| Mihara et al. (2013) [ | RCT | 10/10 | E: 56.1 ± 7.9 C: 60.1 ± 8.5 | E: 146.6 ± 36.2 (d) C: 123.4 ± 38.3 (d) | NIRS, oxyHB | Con-rehab + BCI-visual feedback (MI task) | Con-rehab + sham BCI | 20 min/d, 3 d/wk., 2 wk., 6 d | FMA-UE, ARAT, MAL, fNIRS |
| Ramos-Murguialday et al. (2013) [ | RCT | 16/16 | E: 49.3 ± 12.5 C: 50.3 ± 12.2 | E: 66 ± 45 (mo) C: 71 ± 72 (mo) | EEG, beta | 1 h PT rehab + BCI-orthosis (MA task) | 1 h PT rehab + 1 h sham BCI | 40 min/d, 5 d/wk., 4 wk., 20 d | FMA-UE, GAS, MAL, MAS, task-fMRI |
| Varkuti et al. (2013) [ | NRCT | 6/3 | E: 40.94 ± 14.5 C: 50.67 ± 6.66 | E: 11.67 ± 13.51 (mo) C: 6.8 ± 6.5 (mo) | EEG | BCI-Manus robot (MI task) | Manus robot | 1 h/d, 3 d/wk., 4 wk., 12 d | FMA-UE, RS-fMRI |
| Ang et al. (2014) [ | RCT | 6/8 | E: 54.1 ± 8.9 C: 51.1 ± 6.3 | E: 258.7 ± 64.0 (d) C: 398.2 ± 150.9 (d) | EEG, | 0.5 h mobilization + BCI-robot (MI task) | 0.5 h mobilization + robot | 1.5 h/d, 3 d/wk., 6 wk., 18 d | FMA-UE, |
| Li et al. (2014) [ | RCT | 7/7 | E: 66.3 ± 4.9 C: 67.1 ± 6.0 | E: 2.2 ± 1.8 (mo) C: 2.8 ± 2.0 (mo) | EEG, mu, beta | Con-rehab + BCI-FES (MI task) | Con-rehab + FES | 1–1.5 h/d, 3 d/wk., 24 d, | FMA-UE, ARAT, EEG |
| Rayegani et al. (2014) [ | RCT | 10/10 | E: 51 ± 7.3 C: 54 ± 8.2 | E: 8.5 ± 6 (mo) C: 8 ± 8.8 (mo) | EEG, beta | 1 h con-rehab + BCI-visual feedback (MI task) | Con-rehab | 30 min/d, 5 d/wk., 2 wk., 10 d | JHFT |
| Ang et al. (2015) [ | RCT | 11/14 | E: 48.5 ± 13.5 C: 53.6 ± 9.5 | E: 383.0 ± 290.8 (d) C: 234.7 ± 183.8 (d) | EEG, FBCSP | BCI-Manus robot (MI task) | Manus robot | 1.5 h/d, 3 d/wk., 4 wk., 12 d | FMA-UE |
| Pichiorri et al. (2015) [ | RCT | 14/14 | E: 64.1 ± 8.4 C: 59.6 ± 12.7 | E: 2.7 ± 1.7 (mo) C: 2.5 ± 1.2 (mo) | EEG, 0–60 Hz | 3 h con-rehab + BCI-visual feedback (MI task) | 3 h con-rehab + MI | 30 min/d, 3 d/wk., 4 wk. 12 d | FMA-UE, MRC, MAS, NIHSS, EEG |
| Jang et al. (2016) [ | RCT | 10/10 | E: 61.10 ± 13.77 C: 61.70 ± 12.09 | E: 4.40 ± 0.97 (mo) C: 4.10 ± 0.74 (mo) | EEG, (SMR + mid-beta) / theta | 30 min con-rehab + BCI-FES (AO task) | 30 min con-rehab + FES | 20 min/d, 5 d/wk., 6 wk., 30 d | VD, HD, VAS, MAS, MFT |
| Kim et al. (2016) [ | RCT | 15/15 | E: 59.09 ± 8.07 C: 59.93 ± 9.79 | E: 8.27 ± 1.98 (mo) C: 7.80 ± 1.78 (mo) | EEG, (SMR + mid-beta) / theta | 30 min con-rehab + AO-BCI-FES (AO task) | 30 min con-rehab | 30 min/d, 5 d/wk., 4 wk., 20 d | FMA-UE, MAL, MBI, ROM |
| Frolov et al. (2017) [ | RCT | 55/19 | E: 55.0 ± 12.9 C: 58.5 ± 10.9 | E: 8.9 ± 6.4 (mo) C: 8.8 ± 8.4 (mo) | EEG, 5–30 Hz | Con-rehab + BCI-arm exoskeleton (MI task) | Con-rehab + sham BCI | 30 min/d, 3 d/wk., 12 d | FMA-UE, ARAT, |
| Biasiucci et al. (2018) [ | RCT | 14/13 | E: 56.4 ± 9.9 C: 59.0 ± 12.4 | B: 39.8 ± 45.9 (mo) C: 33.5 ± 30.5 (mo) | EEG, mu, beta | BCI-FES (MA task) | Sham BCI | 1 h/d, 2 d/wk., 5 wk., 10 d | FMA-UE, MRC, MAS, ESS, EEG, |
| Ramos-Murguialday et al. (2019) [ | RCT | 16/12 | E: 49.3 ± 12.5 C: 50.3 ± 12.2 | E: 66 ± 45 (mo) C: 71 ± 72 (mo) | EEG, beta | 1 h PT rehab + 1 h BCI-orthosis (MA task) | 1 h PT rehab + 1 h sham BCI | 1 h/d, 5 d/wk., 4 wk., 20 d | FMA-UE, GAS, MAL, MAS, task-fMRI |
| Ang et al. (2015) [ | RCT | 10/9 | E: 52.1 ± 11.7 C: 56.3 ± 9.5 | E: 1052 ± 722 (d) C: 1021 ± 465 (d) | EEG | 20 min tDCS + BCI- robot (MI task) | 20 min sham tDCS + BCI- robot | 1 h/d, 5 d/wk., 2 wk | FMA-UE |
| Kasashima-Shindo et al. (2015) [ | NRCT | 11/7 | E: 53.5 ± 12.4 C: 48 ± 9.7 | E: 46.2 ± 20.2 (mo) C: 56.4 ± 36.4 (mo) | EEG, mu | 10 min tDCS + BCI-orthosis (MI task) | BCI-orthosis | 45 min/d, 5 d/wk., 2 wk | FMA-UE, MAS |
aData is reported as means (SD)
RCT Randomized control trial, NRCT Non-randomized control trial, E Experimental group, C Control group, BCI Brain-computer interface, NIRS Near-infrared spectroscopy, oxyHB oxygenated hemoglobin, con conventional, MI Motor imagery, AO Action observation, MA Movement attempt, rehab rehabilitation, min minute(s), h hour(s), d day(s), wk. week(s), mo month(s), yr year(s), FMA Fugl-Meyer assessment, UE Upper extremity, LE lower extremity, ARAT Action research arm test, MAL Motor activity log, MAS Modified Ashworth scale, fNIRS functional near-infrared spectroscopy, EEGElectroencephalography, SMR Sensorimotor rhythm, PT Physical therapy, GAS Goal attainment scale, fMRI functional magnetic resonance imaging, RS Resting state, FES functional electrical stimulation, JHFT Jebsen Hand Function Test, MRC Medical Research Council scale, NIHSS National Institute of Health Stroke Scale, VD Vertical distance, HD Horizontal distance, AO Action observation, VAS Visual analogue, MFT The Manual Function Test, MBI Modified Barthel Index, ROM Range of motion, ESS European Stroke Scale, tDCS transcranial direct current stimulation, RMT Resting motor threshold, SICI Short intra-cortical inhibition, ICF Intracortical facilitation
Methodological quality assessment of the controlled studies
| Authors | PEDro items | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | |||
| Mihara et al. (2013) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | |
| Ramos-Murguialday et al. (2013) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | |||
| Varkuti et al. (2013) [ | 1 | 1 | 1 | 1 | 1 | 4 | |||||||
| Ang et al. (2014) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | |||||
| Li et al. (2014) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | ||||
| Rayegani et al. (2014) [ | 1 | 1 | 1 | 1 | 1 | 1 | 5 | ||||||
| Ang et al. (2015) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | |||||
| Pichiorri et al. (2015) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | |||||
| Jang et al. (2016) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | |||||
| Kim et al. (2016) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | ||||
| Frolov et al. (2017) [ | 1 | 1 | 1 | 1 | 1 | 1 | 5 | ||||||
| Biasiucci et al. (2018) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | ||
| Ramos-M et al. (2019) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | |||
| Ang et al. (2015) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | ||||
| Kasashima-Shindo et al. (2015) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | |||||
1 = eligibility criteria; 2 = random allocation; 3 = concealed allocation; 4 = baseline comparability; 5 = blind subjects; 6 = blind therapists; 7 = blind assessors; 8 = adequate follow-up; 9 = intention-to-treat analysis; 10 = between-group comparisons; 11 = point estimates and variability
Fig. 2Comparison of the immediate effects of BCI interventions and control interventions on upper extremity motor function. The change in scores and standard deviations (SD) of both BCI and control groups in the 12 included studies were pooled and the overall effect of the BCIs was computed as a standard mean difference (SMD) with 95% confidence interval. The results indicated that BCI training was significantly effective at improving upper extremity function SMD = 0.42; 95% CI = 0.18–0.66; I2 = 48%; P < 0.001; fixed-effects model)
Fig. 3Meta-regression scatterplots show the relationship between the effect size (standardized mean difference) and number of sessions (a), and the cumulative training time (b). In each subplot, the straight line shows the regression line and the curves around it show the 95% confidence interval
Fig. 4A subgroup analysis for the effects of different BCI mental tasks. The 12 included studies were categorized into motor imagery-based BCIs (eight studies), movement attempt-based BCIs (two studies), and action observation-based BCIs (two studies), depending on the nature of the mental tasks. The results indicted that both movement attempt-based (SMD = 0.69; 95% CI = 0.16–1.22; I2 = 0%; P = 0.010; random-effects model) and action observation-based BCIs (SMD = 1.25; 95% CI = 0.0.05–2.45; I2 = 72%; P = 0.040; random-effects model) tended to show superior clinical effects, compared to MI-based BCIs (SMD = 0.16; 95% CI = − 0.13 – 0.45; I2 = 0%; P = 0.290; random-effects model) in regard to improving upper extremity function. However, the difference among subgroups was not significant (P = 0.070)
Fig. 5A subgroup analysis of the effects of different devices combined with BCIs. The results indicated that only BCIs triggering the stimulation of FES had a significantly large effect size on motor function recovery, compared with control interventions (SMD = 1.04; 95% CI = 0.47–1.62; I2 = 37%; P < 0.001; random-effects model), while both BCIs combined with robots (SMD = 0.04; 95% CI = − 0.30 – 0.38; I2 = 0%; P = 0.820; random-effects model) and with visual feedback (SMD = 0.46; 95% CI = − 0.03 – 0.95; I2 = 0%; P = 0.060; random-effects model) had no significant differential clinical effects with control interventions
Fig. 6A comparison of the long-term effects of BCI interventions and control interventions on upper extremity motor function. The inputted data consisted of the change in scores between baseline and follow-up. Five studies followed up with patients from between 6 weeks to six-to-12 months. Ang et al. followed up with subjects twice after the intervention, after 6 weeks and after 18 weeks [48]. Our meta-analysis indicated that BCIs did not show any significant differential effects compared with control interventions when we used the follow-up data from Ang et al.’s study at 6 weeks [48] (SMD = 0.12; 95% CI = − 0.28 – 0.52; I2 = 0%; P = 0.540; fixed-effects model)
Fig. 7The potentiating effects of tDCS on BCI training in regard to improving upper extremity function. The meta-analysis indicated that the tDCS could not further potentiate the clinical effects of BCIs in regard to improving upper extremity motor function in patients with stroke (SMD = − 0.30; 95% CI = − 0.96 – 0.36; I = 0%; P = 0.370; fixed-effects model)